Key facts
- It has raised $22.4M across 1 recorded rounds; the latest was Seed Round ($255K) in Jul 2023.
- Innovative Trauma Care has filed 2 Form Ds with the SEC since 2023, most recently Jan 2025 ($100K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Innovative Trauma Care
Funding rounds
1 roundsAbout Innovative Trauma Care
Developer of trauma care medical devices designed to provide rapid control of severe bleeding in emergencies. The company offers a patented, FDA-cleared hemorrhage control device that clamps and seals wound edges to stop blood loss, enabling emergency responders, military personnel, and hospital staff to manage difficult-to-control bleeding quickly and improve patient survival outcomes.
- Sector
- Healthcare
- HQ
- San Antonio, TX, United States
- Founded
- 2010
- Employees
- 12
- Website
- innovativetraumacare.com/
- Ownership
- Privately Held (backing)
Innovative Trauma Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innovative Trauma Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innovative Trauma Care in its N-PORT filings yet. We sweep new filings monthly.